NYSE$ATR

AptarGroup Inc. · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

AptarGroup showcased resilient business with strong second half results and record annual free cash flow.

AptarGroup reported strong fourth quarter performance with reported sales growth of 12% and core sales growth of 5%. The Pharma and Food + Beverage segments achieved double-digit sales growth, while the Beauty + Home segment saw modest core sales decline. The company achieved increased earnings per share and strong cash flow from operations and free cash flow.

  • Reported sales grew 12%; core sales grew 5%.
  • Pharma and Food + Beverage segments achieved double-digit sales growth.
  • Reported earnings per share totaled $0.79.
  • Adjusted earnings per share totaled $0.92.

Headline financials

Total Revenue

$749M

Previous: $671M+11.6%
EPS (adj)

$0.92

Previous: $0.80+15.0%
Total Core Sales Growth

5.0%

Previous: -1.0%+600.0%
Pharma Core Sales Growth

10.0%

Previous: 4.0%+150.0%
Beauty Core Sales Growth

-2.0%

Previous: -5.0%+60.0%
Closures Core Sales Growth

13.0%

Previous: -1.0%+1400.0%
Capital Expenditures

$72.6M

Previous: $55.4M+30.9%
Free Cash Flow

$116M

Previous: $78.6M+47.7%
Net Income

$53.2M

Previous: $48.5M+9.7%
Operating Income

$81.5M

Previous: $74.5M+9.4%
Gross Profit

$279M

Previous: $236M+18.4%
Cash & Equivalents

$300M

Previous: $242M+24.0%
Total Assets

$3.99B

Previous: $3.56B+12.0%
Stock-Based Comp

$7.96M

Previous: $5.82M+36.8%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$749M

Q4 2020+11.6%vs Q4 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AptarGroup · $749M total across 3 segments · Q4 2020

  • Beauty
    $337M+6.9%
  • Pharma
    $312M+16.6%
  • Closures
    $101M+13.2%

Forward guidance

Aptar expects earnings per share for the first quarter of 2021 to be in the range of $0.86 to $0.94, based on an effective tax rate range of 28% to 30%. The company anticipates continued solid growth in injectables components, active material solutions, and dispensing systems for sanitizers, cleaners, and food products.

Tailwinds

  • Continued solid growth in injectables components.
  • Continued solid growth in active material solutions.
  • Continued solid growth in dispensing systems for sanitizers.
  • Continued solid growth in dispensing systems for cleaners.
  • Continued solid growth in dispensing systems for food products.

Headwinds

  • Demand in the beauty fragrance market is expected to remain under pressure.
  • Demand in the on-the-go beverage markets is expected to remain under pressure.
  • Experiencing a drawdown of inventories by certain prescription drug customers.
  • Experiencing a drawdown of inventories by certain consumer health care customers.
  • Fewer non-critical doctor visits.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro